Agency / Source: Greenphire, LLC

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Greenphire Named to Inc. 5000 for Fifth Consecutive Year - Global leader in clinical trial payment automation experiences continued growth as a result of increasing industry demand for clinical trial payment lifecycle efficiencies - Inc.com / Greenphire.com
Greenphire Named to Inc. 5000 for Fifth Consecutive Year

 

PRZOOM - /newswire/ - King of Prussia, PA, United States, 2017/08/29 - Global leader in clinical trial payment automation experiences continued growth as a result of increasing industry demand for clinical trial payment lifecycle efficiencies - Inc.com / Greenphire.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Greenphire, the global leader in automated clinical payment solutions, today announced that it has been named to the Inc. 5000 list for the fifth consecutive year, landing the Company a coveted spot on the Honor Roll, a select group of organizations that have demonstrated consistently high growth.

A mere seven percent of companies named to the Inc. 5000 list will be selected five times, marking 2017 as an impressive milestone for Greenphire as it continues to grow its client base and revenues. Greenphire was listed as number 1843 this year, exhibiting 209% growth since 2013.

“Our transformational solutions and services deliver efficiency, control and predictability for Sponsors, CROs and sites, enabling a better clinical trial experience for all end users,” said Jim Murphy, CEO of Greenphire. “Continued growth at this rate for a company of our size is a testament to our ability to build long-term, trusting relationships.”

The clinical trial ecosystem is increasingly focused on both the patient and site experience, resulting in a significant demand for Greenphire’s payment solutions.

Greenphire’s ClinCard, the most widely accepted and adopted clinical trial participant payment, reimbursement and travel solution is designed to reduce any financial barriers that may impact a participant’s ability to remain engaged in the trial, while eliminating the administrative headaches of managing stipends, payments and travel coordination at the site staff. The eClinicalGPS, the most mature, flexible and sophisticated site payment solution in the market is designed to optimize clinical trial operations and deliver financial visibility and control.

Greenphire will be honored at the 36th Annual Inc. 5000 Conference and Gala on October 10-12, 2017 at the JW Marriott Desert Springs Resort & Spa in Palm Desert.

About Greenphire

Greenphire (greenphire.com) is the leader in global clinical trial payment solutions. Greenphire’s best-in-class solutions optimize clinical trial performance by simplifying and streamlining payment processes from sponsors and CROs to sites and patients. Greenphire’s ClinCard and eClinicalGPS solutions easily handle any type of trial design and complexity, resulting in more accurate and compliant payments globally for both sites and patients. The choice of industry leaders worldwide, Greenphire provides better performance and better data, resulting in better trials.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Greenphire, LLC

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Greenphire Named to Inc. 5000 for Fifth Consecutive Year

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
Greenphire’s ClinCard | Inc. 5000
Contact: Press Office - Greenphire.com 
215-609-4378 / 215-609-4640 corporate[.]greenphire.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Greenphire, LLC securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Press Releases From Greenphire, LLC / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Press Releases:

Transgene and NEC Announce Positive Preliminary Data from Phase I Studies of TG4050 - A Novel Individualized Neoantigen Cancer Vaccine
DSM Plans New Production Site for Bovaer® in Dalry, Scotland
Celltrion Pharm Selects TrackWise QMS for Scalability and Data Integrity
Ipsen Adds Another Program into its Pre-clinical R&D Oncology Pipeline through An Exclusive Worldwide Collaboration with Accent Therapeutics
Evaxion Biotech Lauded by Frost & Sullivan for Helping Develop Highly Targeted Therapies with its AI Immunology Platforms
Kyowa Hakko Acclaimed by Frost & Sullivan for its Non-GMO, Allergen-free, Immune Support Paraprobiotic Ingredient, IMMUSE™
DSM to Acquire First Choice Ingredients to Accelerate Growth in Food and Beverage
STEMCELL Technologies Launches Human Pluripotent Stem Cell Characterization and Banking Services in Partnership with WiCell
Biocon Selects TrackWise to Enable Enterprise Quality Management Across Global Biopharmaceutical Operations
STEMCELL Technologies and Hubrecht Organoid Technology to Partner on Non-Oncology Organoid Drug Screening Services

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
.



PREMIUM Members


Visit  JobsWare.com

Visit  Mokuyobi

Visit  La Bella Bakery Artisan Bakery Arizona







 
  ©2021 PRZOOM - Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today